Form 4 for APRE Aprea Therapeutics, Inc.
Accepted 2022-08-01 00:00:00 ET · period of report 2022-07-28 · accession 0001104659-22-084775 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-01 | 2022-07-28 | APRE | Seizinger Bernd R. | Dir | A - Grant | $0.00 | +5,995 | 324.6K | +2% | $0 |
| D | 2022-08-01 | 2022-07-28 | APRE | Seizinger Bernd R. | Dir | A - Grant | $0.00 | +29.6K | 29.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-28 | A | A | 5,995 | $0.00 | 324,575 | D | — | — | (F1) These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions. |
| 2 | Derivative | Stock Option (right to Buy) | 2022-07-28 | A | A | 29,575 | $0.00 | 29,575 | D | $1.09 · — to 2032-07-28 | 29,575 Common Stock | (F2) The option vests in full on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions. |